370 related articles for article (PubMed ID: 24735134)
1. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
2. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
5. Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial.
Reznik Y; Habteab A; Castaneda J; Shin J; Joubert M
Diabetes Obes Metab; 2018 Oct; 20(10):2435-2441. PubMed ID: 29862649
[TBL] [Abstract][Full Text] [Related]
6. When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump.
Cohen O; Filetti S; Castañeda J; Maranghi M; Glandt M
Diabetes Care; 2016 Aug; 39 Suppl 2():S180-6. PubMed ID: 27440831
[TBL] [Abstract][Full Text] [Related]
7. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
[TBL] [Abstract][Full Text] [Related]
12. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
[TBL] [Abstract][Full Text] [Related]
13. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump.
Luo P; Cheng Q; Chen B; Li Y; Wu J; Zhang X; Jiao X; Zhao J; Lv X
Diabetes Technol Ther; 2013 Dec; 15(12):984-9. PubMed ID: 24004044
[TBL] [Abstract][Full Text] [Related]
17. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial.
Metzger M; Castañeda J; Reznik Y; Giorgino F; Conget I; Aronson R; de Portu S; Runzis S; Lee SW; Cohen O
Diabetes Obes Metab; 2017 Oct; 19(10):1490-1494. PubMed ID: 28374511
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
[TBL] [Abstract][Full Text] [Related]
20. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]